Brian Till, MD

Assistant Member
Clinical Research Division
Assistant Professor, Medicine
University of Washington
Attending Physician, Stem Cell Transplant Service
Seattle Cancer Care Alliance

Education:

University of Chicago, 2002, MD

Research Focus:

Dr. Till is developing new immunotherapies for lymphoma, focusing on the approach of adoptive T cell therapy with autologous T lymphocytes genetically engineered to express a chimeric antigen receptor (CAR). Dr. Till, in collaboration with Dr. Press, is planning a clinical trial in patients with lymphoma to test these cells, which will also express a “suicide” gene that allows the cells to be killed in case they cause toxicities or other problems. Dr. Till’s laboratory is also exploring the effects of co-inhibition and co-stimulation on CAR T cells.

Clinical Expertise:

Dr. Till’s clinical expertise is in lymphoma as well as autologous stem cell transplantation.



Related News

Additional Links & Information

Related Labs & Projects

View all labs & projects >
Brian Till, MD

Contact Information

Phone
(206) 667-7269
Fax
(206) 667-1874
Email
Additional contact

Mailstop: D3-190